Vir Biotechnology (VIR) Earnings Analysis
Vir Biotechnology (VIR) has no confirmed upcoming earnings date. Last quarter (2026-02-23) it beat with EPS -0.31 USD vs -0.42 USD est (+26.2%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -2.99.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VIR next report earnings?
No confirmed upcoming earnings date is currently scheduled for VIR. This page updates as the calendar is published.
VIR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | -0.31 USD | -0.42 USD | +26.2% | Beat |
| 2025-02-26 | -0.76 USD | -0.85 USD | +10.6% | Beat |
| 2024-10-31 | -1.56 USD | -0.96 USD | -62.5% | Miss |
| 2024-08-01 | -1.02 USD | -0.93 USD | -9.7% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
VIR valuation and analyst view
| Trailing P/E | -2.99 |
|---|---|
| Trailing EPS | -3.00439 USD |
| Price / book | 1.70 |
| Dividend yield | 0.00% |
| Market cap | 1.57B |
| Analyst consensus | Buy (10 buy / 2 hold / 0 sell) |
| Avg price target | 25 USD |
Related research pages
Frequently asked questions
When is Vir Biotechnology (VIR)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for VIR. This page updates as the calendar is published.
Did VIR beat earnings last quarter?
In its 2026-02-23 report, VIR posted EPS of -0.31 USD versus a -0.42 USD estimate — a beat of 26.2%.
What is VIR's earnings track record?
Over the last 4 reported quarters with consensus data, VIR beat estimates 2 times (50%).
What is VIR's current P/E ratio and EPS?
VIR trades at a trailing P/E of -2.99 on trailing EPS of -3.0043877646076367 USD.
What do analysts rate VIR?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 25 USD.